We hypothesized that the inducible kinin B 1 receptor (B1R) is rapidly cleared from cells when its synthesis subsides. The agonistindependent degradation of the rabbit B 1Rs and related B2 receptors (B2Rs) was investigated. Endocytosis of the B1R-yellow fluorescent protein (YFP) conjugate was more intense than that of B 2R-green fluorescent protein (GFP) based on fluorescence accumulation in HEK 293 cells treated with a lysosomal inhibitor. The cells expressing B 1R-YFP contained more GFP/YFP-sized degradation product(s) than those expressing B 2R-GFP (immunoblot, antibodies equally reacting with both fluorescent proteins). The binding site density of B 1R-YFP decreased in the presence of protein synthesis or maturation inhibitors (anisomycin, brefeldin A), whereas that of B 2R-GFP remained constant. Wild-type B1Rs were also cleared faster than B 2Rs in rabbit smooth muscle cells treated with metabolic inhibitors. Contractility experiments based on brefeldin A-treated isolated rabbit blood vessels also functionally support that B 1Rs are more rapidly eliminated than B 2Rs (decreased maximal effect of agonist over 2 h). The highly regulated B 1R is rapidly degraded, relative to the constitutive B 2R. kinin B2 receptor; rabbit aorta; rabbit jugular vein; smooth muscle cells BRADYKININ (BK)-related peptides (the kinins) stimulate two homolog G protein-coupled receptors (GPCRs), the widely distributed and constitutively expressed B 2 receptor (B 2 R) and the highly regulated B 1 receptor (B 1 R) (17). Several findings support B 1 R importance in late inflammatory events: it is selectively stimulated by a class of abundant class of kinin metabolites formed from the native kinins BK and Lys-BK by carboxypeptidases. Lys-des-Arg 9 -BK (des-Arg 10 -kallidin) is the optimal agonist sequence of the human and rabbit B 1 Rs, and des-Arg 9 -BK is also a selective agonist, but of lower affinity in these species. B 1 R gene expression is inducible under the influence of cytokines, some growth factors, and possibly direct noxious stimuli to cells (13, 17, 26) . The regulation of the two receptor subtypes differs at the protein level: the B 1 R is not importantly internalized after agonist stimulation relative to the B 2 R (10, 33). Accordingly, the B 1 R fails to undergo ligand-induced phosphorylation, whereas the B 2 R is phosphorylated in comparative experiments based on Sf9 cells (6). Agonist-induced cellular redistribution of kinin receptors has been studied with fusion proteins composed of the rabbit B 1 -or B 2 Rs fused with green fluorescent protein (GFP) or its yellow color variant (YFP) (3, 12, 25) . BK induces B 2 R-GFP endocytosis in a recycling endosome compartment, with essentially complete subsequent reexpression at the cell surface (3). Lys-des-Arg 9 -BK induces a condensation of cell surface B 1 R-YFP into aggregates that remain associated with the plasma membrane and that were identified as caveolae-related rafts; this redistribution was slowly reversible on washing at 37°C and distinct from endocytosis (25).
BRADYKININ (BK)-related peptides (the kinins) stimulate two homolog G protein-coupled receptors (GPCRs), the widely distributed and constitutively expressed B 2 receptor (B 2 R) and the highly regulated B 1 receptor (B 1 R) (17) . Several findings support B 1 R importance in late inflammatory events: it is selectively stimulated by a class of abundant class of kinin metabolites formed from the native kinins BK and Lys-BK by carboxypeptidases. Lys-des-Arg 9 -BK (des-Arg 10 -kallidin) is the optimal agonist sequence of the human and rabbit B 1 Rs, and des-Arg 9 -BK is also a selective agonist, but of lower affinity in these species. B 1 R gene expression is inducible under the influence of cytokines, some growth factors, and possibly direct noxious stimuli to cells (13, 17, 26) . The regulation of the two receptor subtypes differs at the protein level: the B 1 R is not importantly internalized after agonist stimulation relative to the B 2 R (10, 33) . Accordingly, the B 1 R fails to undergo ligand-induced phosphorylation, whereas the B 2 R is phosphorylated in comparative experiments based on Sf9 cells (6) . Agonist-induced cellular redistribution of kinin receptors has been studied with fusion proteins composed of the rabbit B 1 -or B 2 Rs fused with green fluorescent protein (GFP) or its yellow color variant (YFP) (3, 12, 25) . BK induces B 2 R-GFP endocytosis in a recycling endosome compartment, with essentially complete subsequent reexpression at the cell surface (3) . Lys-des-Arg 9 -BK induces a condensation of cell surface B 1 R-YFP into aggregates that remain associated with the plasma membrane and that were identified as caveolae-related rafts; this redistribution was slowly reversible on washing at 37°C and distinct from endocytosis (25) .
Cell surface proteins, including receptors, are susceptible to a turnover process. For GPCRs, there is evidence that an agonist-independent (tonic) endocytosis process may be mechanistically distinct from agonist-induced endocytosis (8, 21, 22, 28) . We hypothesized that the rapidly induced B 1 R is subjected to an accelerated cellular degradation when its synthesis subsides. This mechanism would contribute to termination of B 1 R signaling as the inflammatory condition is being resolved. Relatively rapid clearance of B 1 Rs in vivo is suggested in the lipopolysaccharide injection model in the rabbit: a general state of cardiovascular sensitivity to a B 1 R agonist is apparent 5 or 20 h after administration (24) but not any more 48 h after a bolus injection of the bacterial substance (F. Marceau, unpublished data). Also, the local hyperalgesia produced by zymosan injection into the rat paw and mediated in part by the B 1 R occurs in a narrow time window (5). In addition, there is a loss of binding sites corresponding to B 1 Rs after cycloheximide treatment or serum deprivation in cultured rabbit smooth muscle cells (SMCs) (26) . By contrast, the related and constitutive BK B 2 R may be long lived. In the present experiments, we have exploited several previously characterized experimental systems that express natural or recombinant rabbit B 1 -or B 2 Rs to formally address these questions. Cells. The derivation of separate HEK 293 cell lines stably expressing B2R-GFP or B1R-YFP and some of their properties have been described elsewhere (3, 12, 25) . These cells were used in binding assays (24-well plates), confocal microscopy (35-mm petri dishes), and immunoblots of receptors (based on anti-GFP antibodies, see Immunoblot of GFPrelated proteins). Each receptor fusion protein is a highaffinity, functional receptor. HEK 293 cells transiently transfected with GFP-or YFP-expressing vectors (pEGFP-N3 or pEYFP-N1, respectively; Clontech) were used in a comparative immunoblot experiment.
MATERIALS AND METHODS

Drugs
Rabbit aortic SMCs were cultured as previously described (15) ; the identity of these cells was confirmed with immunohistochemistry for the marker ␣-actin (monoclonal antibody from Sigma). Cells were used at passages 3-6, at a stage at which the B1R basal expression is relatively low and its hormonal induction (epidermal growth factor treatment) is high (27) . SMCs derived from the rabbit mesenteric artery were grown in an identical manner; they reportedly express both B1-and B2Rs, as assessed with their functional response (phospholipase A2 and -C activities; calcium metabolism) (19, 30) . Primary rabbit SMC lines were used in the present experiment to evaluate B1R (cells from either artery) and B2R (mesenteric artery cells) clearance in cells that naturally express the receptors at a physiological level (radioligand binding in 12-well plates).
Effect of drugs on subcellular distribution of B1R-YFP or B2R-GFP. Drugs known to inhibit translation (anisomycin) or lysosomal acidification (bafilomycin A1) or an agonist (Lysdes-Arg 9 -BK) were added to the serum-containing culture medium of the stable transfectant HEK 293 cells expressing either B1R-YFP or B2R-GFP, and the subcellular fluorescence distribution was observed without fixation or drug washout with a Bio-Rad 1024 confocal microscope as a function of treatment duration (ϫ60 objective with oil immersion; emission 488 nm).
Immunoblot of GFP-related proteins. This assay was applied to detect GFP-sized COOH-terminal metabolites in HEK 293 cells expressing the protein conjugates composed of rabbit kinin receptors fused to GFP or YFP. Monoclonal antibodies to GFP (clone JL-8, used at dilution 1:1,000) were purchased from Clontech; these antibodies recognize YFP equally well and exhibit an exceptionally low background in extract of nontransfected HEK 293 cells relative to other commercial anti-GFP antibodies for immunoblot applications based on total cell extracts (3, 12) . The technique was applied as generally described elsewhere (3) .
Binding assays. The clearance of kinin receptors was primarily evaluated with binding assays for the various forms of naturally expressed or recombinant B1-or B2Rs in intact cells (12-well plates for SMCs, 24-well plates for HEK 293 cells). Culture medium was replaced by FBS-free medium to which metabolic inhibitors that suppress surface protein synthesis or maturation were added (anisomycin and brefeldin A, respectively). Brefeldin A blocks one or more GTPases that are necessary for vesicle transit in the Golgi apparatus (11) . It is assumed that the blockade of receptor synthesis or maturation will reveal the first-order rate of their degradation process (20) . The concentrations of anisomycin (10 M) and brefeldin A (18 M) used are maximally effective in various in vitro systems (discussed in Refs. 2 and 9); these drugs were used in a time frame compatible with cell viability (Յ6 h) and observed B1R half-life. Time controls in these experiments were established in cells incubated in FBS-free medium. In some experiments, IL-1␤ (5 ng/ml) was added 4 h before treatment with metabolic inhibitors in the complete culture medium. Cells were incubated with a radioligand concentration sufficient to reveal a large fraction of the maximum binding capacity (Bmax; 1 nM for the B1R ligand [ 3 H]Lys-desArg 9 -BK, 3 nM for the B2R ligand BK; 90 and 80 Ci/mmol, respectively; both from Perkin Elmer Life Sciences) (3, 4, 12, 14, 25) . The assays were performed as described for the B1R (25) or the B 2R (12) . A cold competing peptide (1 M Lys-desArg 9 -BK or BK, respectively) was added to some cell wells to determine the nonspecific binding. More extensive characterization of radioligand binding to rabbit mesenteric artery SMCs was performed (saturation, pharmacological profile) to ascertain the identity of naturally expressed receptors.
Contractility assay. A local ethics committee approved the procedures using rabbits (New Zealand White, 1.5-2 kg; Charles River, St. Constant, Canada). Two rabbit blood vessels are extensively characterized as bioassays specific for each kinin receptor subtype: the aorta for the B 1R and the jugular vein for the B 2R (14, 23) . We stimulated these assays with documented agonist drug concentrations and within time frames sufficient for equilibration and compatible with tissue viability (2-7.5 h for the aorta; 1-6 h for the jugular vein). Rabbit aortic rings were suspended under a tension of 2 g in 5-ml tissue baths containing oxygenated (95% O2-5% CO 2) and warmed (37°C) Krebs solution as described previously (13) . Rabbit jugular vein strips were prepared and mounted under a baseline tension of 1 g as described previously, except that captopril was omitted from the formulation of the Krebs medium (12) . Contractility studies in the aortic preparation were based on the construction of cumulative concentration-response curves for des-Arg 9 -BK (a B1R agonist in this tissue). These studies aimed to functionally evidence B1R decay in a system in which there is an intense B1R upregulation (the "postisolation" induction paradigm) (17) . The spontaneous induction of the B1R was allowed to proceed until 4.5 h after isolation in all tissues, with the construction of one des-Arg 9 -BK concentration-effect curve at 3.5 h (control values that were pooled for statistical analysis); protein translation or maturation was then stopped with anisomycin or brefeldin A, respectively, in some tissues. These drugs are documented to prevent completely the induction in isolated rabbit aortas if applied continuously from the beginning of the in vitro incubation (2, 9) . In each tissue, a second concentration-response curve for des-Arg 9 -BK was constructed at 6.5 h. Contractile responses are expressed as percentage of an internal control, the maximal effect of phenylephrine (PE) recorded in each tissue at 1.5 h; the concentration-effect curve of PE was also recorded at 7.5 h to test for metabolic inhibitor specificity and tissue viability. A similar protocol has been applied to the rabbit jugular vein, a B2R-expressing tissue for which BK is a stable contractile agent (18) , in comparative experiments. Histamine was the reference contractile agent in the vein.
Data analysis. Results are expressed as means Ϯ SE, and Mann-Whitney statistics were calculated with the InStat 2.0 computer program (GraphPad Software, San Diego, CA). The parameters of the Scatchard plots (binding data treatment) and first-order decay were calculated with a computer program (29) .
RESULTS
Effect of drugs on HEK 293 cells expressing fluorescent conjugates of rabbit kinin receptors.
Treatment of cells stably expressing B 1 R-YFP with the protein synthesis inhibitor anisomycin (4 h) produced a certain loss of plasma membrane fluorescence relative to control cells (confocal microscopy; Fig. 1, top) . Cells expressing B 2 R-GFP were not apparently influenced by anisomycin treatment (Fig. 1) . To obtain more objective microscopic proof of fluorescent receptor turnover, we treated cells with bafilomycin A 1 , a drug that blocks lysosomal proteases by raising the pH of lysosomes (1, 31) . B 1 R-YFP accumulated into relatively large cytosolic vacuoles in important quantities in bafilomycintreated cells, whereas the drug effect was much less intense in cells expressing B 2 R-GFP (Fig. 1 ). This kind of cellular redistribution of B 1 R-YFP is different from the agonist-induced translocation: for comparison, the effect of 30-min exposure to the agonist Lys-desArg 9 -BK (100 nM) is shown in Fig. 1 [longer agonist treatment produces similar results, as previously described (25) ]. Figure 1 , bottom, shows that the anti-GFP monoclonal antibody used reacts minimally with a total extract of nontransfected HEK 293 cells; furthermore, it recognizes both GFP and YFP equally well as ϳ27-kDa bands. Cells stably expressing B 2 R-GFP (a 101-to 105-kDa fusion protein; Refs. 3, 12) also contained a faint band identifying a COOH-terminal fragment of a size similar to that of GFP (Fig. 1) . HEK 293 cells stably expressing B 1 R-YFP exhibited a much more intense concentration of YFPsized proteins (Fig. 1) . The fusion protein B 1 R-YFP cannot be identified with certainty in these immunoblots.
Immunoblot of GFP-related proteins from cells expressing B 2 R-GFP or B 1 R-YFP.
Clearance of kinin receptors addressed with radioligands and metabolic inhibitors. In this series of experiments, cells expressing natural or recombinant rabbit kinin receptors were exposed to metabolic inhibitors for up to 6 h to isolate the agonist-independent receptor clearance in the absence of new receptor synthesis. Anisomycin (10 M) has been preferred to cycloheximide to inhibit translation because of a higher potency and stability in biological milieus. A series of experiments were based on two separate HEK 293 cell lines that stably express fluorescent conjugates of rabbit B 1 -and B 2 Rs; B 2 R-GFP is expressed at a three-to fourfold higher density than B 1 R-YFP in resting cells as assessed by the binding of their respective radioligands, Fig. 2 , corresponding approximately to 404 and 1,547 fmol/mg protein). The binding site density corresponding to B 1 R-YFP decreased sharply in HEK 293 cells during the 6-h anisomycin treatment [extrapolated half-life (t 1/2 ) ϭ 6.5 h]; that of the B 2 R fusion protein was essentially constant (values not different from baseline density). The time control curves in Fig. 2 describe the binding site density in cells incubated in FBS-free medium from time 0, but without the metabolic inhibitors. Brefeldin A treatment (6 h) was at least as effective as anisomycin to decrease the density of surface binding sites in cells expressing B 1 R-YFP ( Fig. 2A ; t 1/2 ϭ 5.2 h) but decreased the density of B 2 R-GFP by only ϳ15% (Fig.  2B) . In cells expressing B 1 R-YFP and exposed to metabolic inhibitors, the binding site decay rate is slower than expected from the first-order decay kinetics after 4 h. This may be due to the toxicity of the applied drugs over this relatively long time period.
Rabbit vascular SMCs were used as sources of natural kinin receptors expressed at physiological levels. Cultured rabbit aortic SMCs express a regulated population of B 1 Rs mediating such effects as phosphoinositide hydrolysis, prostaglandin release, and DNA synthesis stimulation (15, 16) Fig. 3A . Anisomycin treatment of rabbit aorta SMCs reveals that the B 1 R is cleared rapidly from the cells ( Fig. 3A; calculated t 1/2 1.9 h). Brefeldin A treatment also induced the clearance of surface receptors ( Fig. 3A ; t 1/2 ϭ 2.6 h). As documented previously (26), treatment of rabbit aortic cells with IL-1␤ for 4 h increases the binding site density by approximately threefold (Fig. 3B) . Adding brefeldin A for a supplemental incubation of 2 h reduced the B 1 R density by ϳ40%; anisomycin was less effective in this respect (Fig. 3B) .
Mesenteric artery SMCs express both B 1 -and B 2 Rs, as assessed by phospholipase A 2 and -C activities and intracellular calcium responses (19, 30 (Fig. 4, A and B) . Binding competition by a panel of cold peptides (each at 1 M) supports the identity of the binding sites as B 1 Rs: the specific binding was abolished by an excess of the nonradioactive version of the B 1 R agonist radioligand and extensively reduced by the B 1 R antagonist Lys-[Leu 8 ]des-Arg 9 -BK but marginally affected by BK or the B 2 R-selective antagonist HOE 140 (Fig. 4C) Fig. 5D to Fig. 4D) .
Kinin receptor function as modified by metabolic inhibitors in contractility assays based on rabbit blood vessels. The isolated rabbit aorta exhibits a progressively increasing maximal contractile response to the B 1 R agonist des-Arg 9 -BK, as evidenced by comparing responses recorded at 3.5 h (pooled controls) and 6.5 h (control) after isolation (Fig. 6A) . In some tissues, the metabolic inhibitors anisomycin or brefeldin A were applied from 4.5 h on. The maximal effect of the agonist recorded at 6.5 h was inferior to that recorded at 3.5 h in tissues treated with brefeldin A (P ϭ 0.03, MannWhitney test) but not in those treated with anisomycin. The response to the ␣-adrenoceptor agonist phenylephrine somewhat increased from the beginning (1.5 h) to the end (7.5 h) of the experiment, but the late response was not affected by the metabolic inhibitors (Fig. 6B) .
The contraction mediated by the B 2 R agonist BK is very stable during in vitro incubation in the rabbit jugular vein (18) , as documented here at 2 and 5 h after isolation (Fig. 7A) . Brefeldin A treatment, applied from 2.5 h on, did not influence the late response to BK. As in the aorta with phenylephrine, the contractile response to histamine increased from the beginning (1 h) to the end (6 h) of the protocol, but the late response was not affected by brefeldin A (Fig. 7B) .
DISCUSSION
Various well-characterized experimental systems expressing rabbit kinin receptors have been exploited to test a novel hypothesis: the B 1 R population, which is rapidly induced after tissue injury (17) , could also be rapidly destroyed in an agonist-independent manner when inflammation subsides. A comparison with the structurally related BK B 2 R has been made, because the latter subtype is constitutively expressed and could be more stable. While studying the properties of the two types of rabbit kinin receptor fused to fluorescent proteins (3, 12, 25) , we repeatedly observed that immunoblots based on different anti-GFP antibodies revealed B 2 R-GFP but little free GFP in a stable transfectant cell line expressing the B 2 R construction. Conversely, immunoreactive B 1 R-YFP was hardly detectable but YFP-sized proteins were abundant in two independent lines of HEK 293 cells stably expressing B 1 R-YFP. The absolute abundance of B 1 R-YFP (radioligand binding, membrane fluorescence intensity) was substantially less than that of B 2 R-GFP in stably transfected HEK 293 cells, although the constructions are expressed under the control of the same promoter. The membrane fluorescence is interpreted as the fusion protein because GFP-related proteins dissolve in total cellular water. A possible model integrating these observations is that the B 1 R construction Fig. 6 . Change in the concentration-effect curve of the B1R agonist des-Arg 9 -BK as a function of incubation time and drug treatment in rabbit aortic rings. A: control concentration-effect curve was constructed for the peptide in each tissue at 3.5 h from the beginning of the in vitro incubation. A drug was then continuously applied from 4.5 h on, and the concentration-effect curve was constructed again for des-Arg 9 -BK at 6.5 h. Contractile responses are expressed as % of an internal control, the maximal effect of phenylephrine (PE) recorded in each tissue at 1.5 h. B: concentration-effect curve of PE was also recorded at 7.5 h to test for drug effect specificity and tissue viability. Values are means Ϯ SE of n determinations. is short lived relative to the B 2 R-based fusion protein.
Thus at equilibrium B 1 R-YFP abundance at the cell surface would be inferior to that of B 2 R-GFP because these proteins are cleared at a different rate, even if formed at a similar rate. GFP, a stable and compact globulin, has a long half-life in mammalian cells (7) , and its accumulation is a sensitive indicator of partial receptor-GFP conjugate degradation (as previously observed with endothelin ET B receptor-GFP, which is bound to lysosomal degradation in a largely agonistindependent manner) (1). We have validated that the presence of GFP-related proteins in HEK 293 cells is an indicator of B 2 R-GFP degradation, because the treatment of intact cells with trypsin leads to GFP accumulation in 10 min (3). Thus immunoblot results constitute circumstantial evidence that B 1 R-YFP is submitted to tonic, agonist-independent degradation.
Brefeldin A prevents the translocation of newly formed proteins from the endoplasmic reticulum to the Golgi apparatus (11) and is highly effective to prevent the de novo formation of B 1 R in the rabbit aorta (2) . Treatments with the metabolic inhibitors anisomycin and brefeldin A allowed us to observe the agonistindependent decay of either B 1 R-YFP or wild-type B 1 R as assessed with radioligand binding (Figs. 2-4) . In comparative experiments, B 2 R-GFPs or wild-type B 2 Rs were more stable (Figs. 2 and 5) . Comparison with naturally expressed receptors is important because conjugation with GFP-related proteins may theoretically induce conformational changes that could favor receptor degradation. The recorded or extrapolated t 1/2 values from both HEK 293 cells and SMCs show that GFP/YFP conjugation does not change the large stability difference between the kinin receptor subtypes. Moreover, the clearance difference between the wildtype B 1 R and B 2 R is maintained when receptors are expressed by the same cell type, the mesenteric artery SMCs. The B 1 R may be further routed to lysosomal degradation, as suggested by the accumulation of intracellular fluorescence in vesicles in B 1 R-YFP-expressing cells treated with bafilomycin A 1 (interrupted lysosomal function; Fig. 1) .
We have further attempted to validate our findings in contractility assays based on freshly isolated rabbit blood vessels. A limitation of this comparison is the different identity of the tissues, with possible consequences such as differences in membrane composition and stability. Furthermore, a potential problem with the B 1 R bioassay, the aorta, is the effect of time on the system. The progressive increase of the B 1 R agonist maximal effect in the rabbit aorta has been found to be sizeable during the period 3.5-6.5 h (Fig. 6) , because the system is subject to postisolation receptor synthesis (2, 26) . Evidencing receptor degradation in this special experimental context, where a cohort of receptors is presumably maturing in the "secretory pathway" (reticulum-Golgi), is based on metabolic inhibitors. Anisomycin is just able to maintain the B 1 Rmediated response at the preapplication level (Fig. 6) , perhaps because the drug does not block receptor maturation and receptors emerging from the secretory pathway compensate for the lost ones. Brefeldin A is more effective, producing a significant loss of B 1 Rmediated function over the 2-h observation period, because it may block B 1 R maturation (Fig. 6) . The drug acts with specificity, having no inhibitory action on phenylephrine-induced aortic contraction relative to similarly aged control preparations. Similarly, brefeldin A was more effective to decrease the density of B 1 Rs than anisomycin in cultured SMCs only when the cells were pretreated with IL-1␤ (Fig. 3B) , probably for the same reason (secretory pathway not immediately inhibited by anisomycin). Treatments with either brefeldin A or anisomycin do not influence the functional response to BK in the rabbit jugular vein (Fig. 7) , supporting that the B 2 R population is not rapidly eliminated from the preparation.
Structural determinants of B 1 R antagonist-independent degradation remain to be identified. In some cases, separate motifs present in the COOH-terminal tail of some GPCRs determine agonist-induced endocytosis and tonic internalization (in receptors for thromboxane or thrombin) (21, 28) . Whereas the first type of motif supports receptor phosphorylation, the second type does not in the two cited examples. The specificity of the present system may be that the spontaneously internalized B 1 R undergoes minimal agonist-induced internalization and no phosphorylation (see introductory paragraphs). There is evidence that the phosphorylation motif in the delta-opioid receptor tail repels arrestin-3 specifically when not phosphorylated (32) , suggesting that the presence of such a motif in the B 2 R, and its absence in the B 1 R, may be sufficient to account for kinin receptor turnover differences. The cytokineand tissue injury-induced B 1 R is subjected to an accelerated degradation, perhaps to adjust the receptor population to the inflammatory stimulus, relative to the B 2 R, which may be more economically managed (constitutively expressed, completely recycled, long-lived at the protein level).
